marion merrell dow us pharmaceuticals group looking substantial paneuropean acquisition according senior company executives the aim acquisition would increase sales european prescription drugs overthecounter nonprescription businesses the group generates 30 per cent turnover outside us 23 per cent europe marion merrell dow would also like acquire manufacturing capacity says mr ronald irwin chairman managing director marion merrell dows uk operations the groups british production site acquired procter gamble us consumer products group bought richardsonvicks 1986 marion merrell dow uses contract manufacturers mr irwin says group considerable cash reserves make acquisition cash shortterm investments end last year dollars 414m however another route available company might merger merchant bankers known approached least one leading british pharmaceuticals group suggesting deal any european acquisition would compliment marion merrell dows purchase last year berlinbased pharmaceuticals group henning in 1991 us group attempted acquire nicholas labs european otc business us company sara lee eventually bought roche switzerland dollars 790m the us group needs drive earnings acquisitions us patents two leading products cardizem seldane due expire within next two years sales nicoderm nicotine patch together nicorette nicotine gum increased 122 per cent last year however expected slow year